Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. McEwen, BS
   Genome and hormones: Gender differences in physiology - Invited review: Estrogens effects on the brain: multiple sites and molecular mechanisms
   JOURNAL OF APPLIED PHYSIOLOGY
   
   B.S. McEwen, "Genome and hormones: Gender differences in physiology - Invited review: Estrogens effects on the brain: multiple sites and molecular mechanisms", J APP PHYSL, 91(6), 2001, pp. 2785-2801
2. Hass, S; Weidemann, A; Utermann, G; Baier, G
   Intracellular apolipoprotein E affects amyloid precursor protein processing and amyloid A beta production in COS-1 cells
   MOLECULAR GENETICS AND GENOMICS
   
   S. Hass et al., "Intracellular apolipoprotein E affects amyloid precursor protein processing and amyloid A beta production in COS-1 cells", MOL GENET G, 265(5), 2001, pp. 791-800
3. Nalivaeva, NN; Turner, AJ
   Post-translational modifications of proteins: Acetylcholinesterase as a model system
   PROTEOMICS
   
   N.N. Nalivaeva e A.J. Turner, "Post-translational modifications of proteins: Acetylcholinesterase as a model system", PROTEOMICS, 1(6), 2001, pp. 735-747
4. Bieber, EJ; Cohen, DP
   Estrogens and hormone replacement therapy: Is there a role in the preservation of cognitive function?
   INTERNATIONAL JOURNAL OF FERTILITY AND WOMENS MEDICINE
   
   E.J. Bieber e D.P. Cohen, "Estrogens and hormone replacement therapy: Is there a role in the preservation of cognitive function?", INT J F W M, 46(4), 2001, pp. 206-209
5. Linn, ES; Kaunitz, AM; Schnare, S; Taylor, M
   The hormone continuum: Accrual of women's health benefits
   INTERNATIONAL JOURNAL OF FERTILITY AND WOMENS MEDICINE
   
   E.S. Linn et al., "The hormone continuum: Accrual of women's health benefits", INT J F W M, 46(2), 2001, pp. 60-72
6. Vielhaber, E; Virshup, DM
   Casein kinase I: From obscurity to center stage
   IUBMB LIFE
   
   E. Vielhaber e D.M. Virshup, "Casein kinase I: From obscurity to center stage", IUBMB LIFE, 51(2), 2001, pp. 73-78
7. Blauw, GJ; Bollen, ELEM; van Buchem, MA; Westendorp, RGJ
   Dementia at old age: a clinical end-point of atherosclerotic disease
   EUROPEAN HEART JOURNAL SUPPLEMENTS
   
   G.J. Blauw et al., "Dementia at old age: a clinical end-point of atherosclerotic disease", EUR H J SUP, 3(N), 2001, pp. N16-N19
8. Potkin, SG; Anand, R; Fleming, K; Alva, G; Keator, D; Carreon, D; Messina, J; Wu, JC; Hartman, R; Fallon, JH
   Brain metabolic and clinical effects of rivastigmine in Alzheimer's disease
   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
   
   S.G. Potkin et al., "Brain metabolic and clinical effects of rivastigmine in Alzheimer's disease", IN J NEUROP, 4(3), 2001, pp. 223-230
9. Friedhoff, LT; Cullen, EI; Geoghagen, NSM; Buxbaum, JD
   Treatment with controlled-release lovastatin decreases serum concentrations of human beta-amyloid (A beta) peptide
   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
   
   L.T. Friedhoff et al., "Treatment with controlled-release lovastatin decreases serum concentrations of human beta-amyloid (A beta) peptide", IN J NEUROP, 4(2), 2001, pp. 127-130
10. Joosten, E
    Homocysteine, vascular dementia and Alzheimer's disease
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE
    
    E. Joosten, "Homocysteine, vascular dementia and Alzheimer's disease", CLIN CH L M, 39(8), 2001, pp. 717-720
11. de Ceballos, ML; Brera, B; Fernandez-Tome, MP
    beta-Amyloid-induced cytotoxicity, peroxide generation and blockade of glutamate uptake in cultured astrocytes
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE
    
    M.L. de Ceballos et al., "beta-Amyloid-induced cytotoxicity, peroxide generation and blockade of glutamate uptake in cultured astrocytes", CLIN CH L M, 39(4), 2001, pp. 317-318
12. Near, SE; Wang, J; Hegele, RA
    Single nucleotide polymorphisms of the very low density lipoprotein receptor (VLDLR) gene
    JOURNAL OF HUMAN GENETICS
    
    S.E. Near et al., "Single nucleotide polymorphisms of the very low density lipoprotein receptor (VLDLR) gene", J HUM GENET, 46(8), 2001, pp. 490-493
13. Lautenschlager, NT; Riemenschneider, M; Drzezga, A; Kurz, AF
    Primary degenerative mild cognitive impairment: Study population, clinical, brain imaging and biochemical findings
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    
    N.T. Lautenschlager et al., "Primary degenerative mild cognitive impairment: Study population, clinical, brain imaging and biochemical findings", DEMENT G C, 12(6), 2001, pp. 379-386
14. Scherder, E; Bouma, A; Slaets, J; Ooms, M; Ribbe, M; Blok, A; Sergeant, J
    Repeated pain assessment in Alzheimer's disease
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    
    E. Scherder et al., "Repeated pain assessment in Alzheimer's disease", DEMENT G C, 12(6), 2001, pp. 400-407
15. Liou, YJ; Lai, IC; Hong, CJ; Liu, HC; Liu, TY; Tsai, SJ
    Association analysis of the partially duplicated alpha 7 nicotinic acetylcholine receptor genetic variant and Alzheimer's disease
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    
    Y.J. Liou et al., "Association analysis of the partially duplicated alpha 7 nicotinic acetylcholine receptor genetic variant and Alzheimer's disease", DEMENT G C, 12(5), 2001, pp. 301-304
16. Nicosia, F; Alberici, A; Benussi, L; Gasparini, L; Ghidoni, R; Mazzoli, F; Zanetti, O; Frisoni, GB; Geroldi, C; Binetti, G
    Analysis of alpha-2-macroglobulin-2 allele as a risk factor in Alzheimer'sdisease
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    
    F. Nicosia et al., "Analysis of alpha-2-macroglobulin-2 allele as a risk factor in Alzheimer'sdisease", DEMENT G C, 12(5), 2001, pp. 305-308
17. Tarkowski, E; Liljeroth, AM; Nilsson, A; Minthon, L; Blennow, K
    Decreased levels of intrathecal interleukin 1 receptor antagonist in Alzheimer's disease
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    
    E. Tarkowski et al., "Decreased levels of intrathecal interleukin 1 receptor antagonist in Alzheimer's disease", DEMENT G C, 12(5), 2001, pp. 314-317
18. Nebu, A; Ikeda, M; Fukuhara, R; Shigenobu, K; Maki, N; Hokoishi, K; Komori, K; Yasuoka, T; Tanabe, H
    Relationship between blood flow kinetics and severity of Alzheimer's disease: Assessment of severity using a questionnaire-type examination, Alzheimer's disease assessment scale, cognitive sub-scale (ADAS(cog))
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    
    A. Nebu et al., "Relationship between blood flow kinetics and severity of Alzheimer's disease: Assessment of severity using a questionnaire-type examination, Alzheimer's disease assessment scale, cognitive sub-scale (ADAS(cog))", DEMENT G C, 12(5), 2001, pp. 318-325
19. Davidsson, P; Bogdanovic, N; Lannfelt, L; Blennow, K
    Reduced expression of amyloid precursor protein, presenilin-1 and rab3a incortical brain regions in Alzheimer's disease
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    
    P. Davidsson et al., "Reduced expression of amyloid precursor protein, presenilin-1 and rab3a incortical brain regions in Alzheimer's disease", DEMENT G C, 12(4), 2001, pp. 243-250
20. Sjogren, M; Davidsson, P; Gottfries, J; Vanderstichele, H; Edman, A; Vanmechelen, E; Wallin, A; Blennow, K
    The cerebrospinal fluid levels of tau, growth-associated protein-43 and soluble amyloid precursor protein correlate in Alzheimer's disease, reflecting a common pathophysiological process
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    
    M. Sjogren et al., "The cerebrospinal fluid levels of tau, growth-associated protein-43 and soluble amyloid precursor protein correlate in Alzheimer's disease, reflecting a common pathophysiological process", DEMENT G C, 12(4), 2001, pp. 257-264
21. Swainson, R; Hodges, JR; Galton, CJ; Semple, J; Michael, A; Dunn, BD; Iddon, JL; Robbins, TW; Sahakian, BJ
    Early detection and differential diagnosis of Alzheimer's disease and depression with neuropsychological tasks
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    
    R. Swainson et al., "Early detection and differential diagnosis of Alzheimer's disease and depression with neuropsychological tasks", DEMENT G C, 12(4), 2001, pp. 265-280
22. Smith, MZ; Esiri, MM; Barnetson, L; King, E; Nagy, Z
    Constructional apraxia in Alzheimer's disease: Association with occipital lobe pathology and accelerated cognitive decline
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    
    M.Z. Smith et al., "Constructional apraxia in Alzheimer's disease: Association with occipital lobe pathology and accelerated cognitive decline", DEMENT G C, 12(4), 2001, pp. 281-288
23. Doody, RS; Dunn, JK; Clark, CM; Farlow, M; Foster, NL; Liao, T; Gonzales, N; Lai, E; Massman, P
    Chronic donepezil treatment is associated with slowed cognitive decline inAlzheimer's disease
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    
    R.S. Doody et al., "Chronic donepezil treatment is associated with slowed cognitive decline inAlzheimer's disease", DEMENT G C, 12(4), 2001, pp. 295-300
24. Pagani, M; Salmaso, D; Ramstrom, C; Jonsson, C; Lundqvist, R; Thurfjell, L; Schnell, PO; Wagner, A; Jacobsson, H; Larsson, SA
    Mapping pathological Tc-99m-d,I-hexamethylpropylene amine oxime uptake in Alzheimer's disease and frontal lobe dementia with SPECT
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    
    M. Pagani et al., "Mapping pathological Tc-99m-d,I-hexamethylpropylene amine oxime uptake in Alzheimer's disease and frontal lobe dementia with SPECT", DEMENT G C, 12(3), 2001, pp. 177-184
25. Imamura, T; Ishii, K; Hirono, N; Hashimoto, M; Tanimukai, S; Kazui, H; Hanihara, T; Sasaki, M; Mori, E
    Occipital glucose metabolism in dementia with Lewy bodies with and withoutparkinsonism: A study using positron emission tomography
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    
    T. Imamura et al., "Occipital glucose metabolism in dementia with Lewy bodies with and withoutparkinsonism: A study using positron emission tomography", DEMENT G C, 12(3), 2001, pp. 194-197
26. Barber, R; McKeith, IG; Ballard, C; Gholkar, A; O'Brien, JT
    A comparison of medial and lateral temporal lobe atrophy in dementia with Lewy bodies and Alzheimer's disease: Magnetic resonance imaging volumetric study
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    
    R. Barber et al., "A comparison of medial and lateral temporal lobe atrophy in dementia with Lewy bodies and Alzheimer's disease: Magnetic resonance imaging volumetric study", DEMENT G C, 12(3), 2001, pp. 198-205
27. Sjobeck, M; Englund, E
    Alzheimer's disease and the cerebellum: A morphologic study on neuronal and glial changes
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    
    M. Sjobeck e E. Englund, "Alzheimer's disease and the cerebellum: A morphologic study on neuronal and glial changes", DEMENT G C, 12(3), 2001, pp. 211-218
28. Yoo, BC; Cairns, N; Fountoulakis, M; Lubec, G
    Synaptosomal proteins, beta-soluble N-ethylmaleimide-sensitive factor attachment protein (beta-SNAP), gamma-SNAP and synaptotagmin 1 in brain of patients with Down syndrome and Alzheimer's disease
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    
    B.C. Yoo et al., "Synaptosomal proteins, beta-soluble N-ethylmaleimide-sensitive factor attachment protein (beta-SNAP), gamma-SNAP and synaptotagmin 1 in brain of patients with Down syndrome and Alzheimer's disease", DEMENT G C, 12(3), 2001, pp. 219-225
29. Okuda, B; Tachibana, H; Kawabata, K; Takeda, M; Sugita, M
    Comparison of brain perfusion in corticobasal degeneration and Alzheimer'sdisease
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    
    B. Okuda et al., "Comparison of brain perfusion in corticobasal degeneration and Alzheimer'sdisease", DEMENT G C, 12(3), 2001, pp. 226-231
30. Oremus, M; Wolfson, C; Perrault, A; Demers, L; Momoli, F; Moride, Y
    Interrater reliability of the modified Jadad quality scale for systematic reviews of Alzheimer's disease drug trials
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    
    M. Oremus et al., "Interrater reliability of the modified Jadad quality scale for systematic reviews of Alzheimer's disease drug trials", DEMENT G C, 12(3), 2001, pp. 232-236
31. Yamagata, K; Urakami, K; Ikeda, K; Ji, Y; Adachi, Y; Arai, H; Sasaki, H; Sato, K; Nakashima, K
    High expression of apolipoprotein e mRNA in the brains with sporadic Alzheimer's disease
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    
    K. Yamagata et al., "High expression of apolipoprotein e mRNA in the brains with sporadic Alzheimer's disease", DEMENT G C, 12(2), 2001, pp. 57-62
32. Scacchi, R; Gambina, G; Martini, MC; Ruggeri, M; Ferrari, G; Silvestri, M; Schiavon, R; Corbo, RM
    Polymorphisms of the apolipoprotein E gene regulatory region and of the LDL receptor gene in late-onset Alzheimer's disease in relation to the plasmalipidic pattern
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    
    R. Scacchi et al., "Polymorphisms of the apolipoprotein E gene regulatory region and of the LDL receptor gene in late-onset Alzheimer's disease in relation to the plasmalipidic pattern", DEMENT G C, 12(2), 2001, pp. 63-68
33. Aerssens, J; Raeymaekers, P; Lilienfeld, S; Geerts, H; Konings, F; Parys, W
    APOE genotype: No influence on galantamine treatment efficacy nor on rate of decline in Alzheimer's disease
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    
    J. Aerssens et al., "APOE genotype: No influence on galantamine treatment efficacy nor on rate of decline in Alzheimer's disease", DEMENT G C, 12(2), 2001, pp. 69-77
34. Nobili, F; Copello, F; Buffoni, F; Vitali, P; Girtler, N; Bordoni, C; Safaie-Semnani, E; Mariani, G; Rodriguez, G
    Regional cerebral blood flow and prognostic evaluation in Alzheimer's disease
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    
    F. Nobili et al., "Regional cerebral blood flow and prognostic evaluation in Alzheimer's disease", DEMENT G C, 12(2), 2001, pp. 89-97
35. Eckert, A; Oster, M; Zerfass, R; Hennerici, M; Muller, WE
    Elevated levels of fragmented DNA nucleosomes in native and activated lymphocytes indicate an enhanced sensitivity to apoptosis in sporadic Alzheimer's disease - Specific differences to vascular dementia
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    
    A. Eckert et al., "Elevated levels of fragmented DNA nucleosomes in native and activated lymphocytes indicate an enhanced sensitivity to apoptosis in sporadic Alzheimer's disease - Specific differences to vascular dementia", DEMENT G C, 12(2), 2001, pp. 98-105
36. Braunewell, KH; Riederer, P; Spilker, C; Gundelfinger, ED; Bogerts, B; Bernstein, HG
    Abnormal localization of two neuronal calcium sensor proteins, visinin-like proteins (VILIPs)-1 and -3, in neocortical brain areas of Alzheimer disease patients
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    
    K.H. Braunewell et al., "Abnormal localization of two neuronal calcium sensor proteins, visinin-like proteins (VILIPs)-1 and -3, in neocortical brain areas of Alzheimer disease patients", DEMENT G C, 12(2), 2001, pp. 110-116
37. Yamada, M; Itoh, Y; Sodeyama, N; Suematsu, N; Otomo, E; Matsushita, M; Mizusawa, H
    Senile dementia of the neurofibrillary tangle type: A comparison with Alzheimer's disease
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    
    M. Yamada et al., "Senile dementia of the neurofibrillary tangle type: A comparison with Alzheimer's disease", DEMENT G C, 12(2), 2001, pp. 117-126
38. Blomberg, M; Jensen, M; Basun, H; Lannfelt, L; Wahlund, LO
    Cerebrospinal fluid tau levels increase with age in healthy individuals
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    
    M. Blomberg et al., "Cerebrospinal fluid tau levels increase with age in healthy individuals", DEMENT G C, 12(2), 2001, pp. 127-132
39. McCaddon, A; Hudson, P; Abrahamsson, L; Olofsson, H; Regland, B
    Analogues, ageing and aberrant assimilation of vitamin B12 in Alzheimer's disease
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    
    A. McCaddon et al., "Analogues, ageing and aberrant assimilation of vitamin B12 in Alzheimer's disease", DEMENT G C, 12(2), 2001, pp. 133-137
40. Lesser, G; Kandiah, K; Libow, LS; Likourezos, A; Breuer, B; Marin, D; Mohs, R; Haroutunian, V; Neufeld, R
    Elevated serum total and LDL cholesterol in very old patients with Alzheimer's disease
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    
    G. Lesser et al., "Elevated serum total and LDL cholesterol in very old patients with Alzheimer's disease", DEMENT G C, 12(2), 2001, pp. 138-145
41. Leuba, G; Saini, K; Zimmermann, V; Giannakopoulos, P; Bouras, C
    Mild amyloid pathology in the primary visual system of nonagenarians and centenarians
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    
    G. Leuba et al., "Mild amyloid pathology in the primary visual system of nonagenarians and centenarians", DEMENT G C, 12(2), 2001, pp. 146-152
42. Nebu, A; Ikeda, M; Fukuhara, R; Komori, K; Maki, N; Hokoishi, K; Shigenobu, K; Kikuchi, T; Tanabe, H
    Utility of Tc-99m-HM-PAO SPECT hippocampal image to diagnose early stages of Alzheimer's disease using semiquantitative analysis
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    
    A. Nebu et al., "Utility of Tc-99m-HM-PAO SPECT hippocampal image to diagnose early stages of Alzheimer's disease using semiquantitative analysis", DEMENT G C, 12(2), 2001, pp. 153-157
43. Novella, JL; Ankri, J; Morrone, I; Guillemin, F; Jolly, D; Jochum, C; Ploton, L; Blanchard, F
    Evaluation of the quality of life in dementia with a generic quality of life questionnaire: The Duke Health Profile
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    
    J.L. Novella et al., "Evaluation of the quality of life in dementia with a generic quality of life questionnaire: The Duke Health Profile", DEMENT G C, 12(2), 2001, pp. 158-166
44. Power, DA; Noel, J; Collins, R; O'Neill, D
    Circulating leptin levels and weight loss in Alzheimer's disease patients
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    
    D.A. Power et al., "Circulating leptin levels and weight loss in Alzheimer's disease patients", DEMENT G C, 12(2), 2001, pp. 167-170
45. Kawano, M; Ichimiya, A; Ogomori, K; Kuwabara, Y; Sasaki, M; Yoshida, T; Tashiro, N
    Relationship between both IQ and Mini-Mental State Examination and the regional cerebral glucose metabolism in clinically diagnosed Alzheimer's disease: A PET study
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    
    M. Kawano et al., "Relationship between both IQ and Mini-Mental State Examination and the regional cerebral glucose metabolism in clinically diagnosed Alzheimer's disease: A PET study", DEMENT G C, 12(2), 2001, pp. 171-176
46. Brane, G; Gottfries, CG; Winblad, B
    The Gottfries-Brane-Steen Scale: Validity, reliability and application in anti-dementia drug trials
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    
    G. Brane et al., "The Gottfries-Brane-Steen Scale: Validity, reliability and application in anti-dementia drug trials", DEMENT G C, 12(1), 2001, pp. 1-14
47. Hirono, N; Mori, E; Ishii, K; Imamura, T; Tanimukai, S; Kazui, H; Hashimoto, M; Takatsuki, Y; Kitagaki, H; Sasaki, M
    Neuronal substrates for semantic memory: A positron emission tomography study in Alzheimer's disease
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    
    N. Hirono et al., "Neuronal substrates for semantic memory: A positron emission tomography study in Alzheimer's disease", DEMENT G C, 12(1), 2001, pp. 15-21
48. Almkvist, O; Jelic, V; Amberla, K; Hellstrom-Lindahl, E; Meurling, L; Nordberg, A
    Responder characteristics to a single oral dose of cholinesterase inhibitor: A double-blind placebo-controlled study with tacrine in Alzheimer patients
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    
    O. Almkvist et al., "Responder characteristics to a single oral dose of cholinesterase inhibitor: A double-blind placebo-controlled study with tacrine in Alzheimer patients", DEMENT G C, 12(1), 2001, pp. 22-32
49. Neill, D; Hughes, D; Leake, A; Morris, C; Jones, D; Oakley, A; Edwardson, J; Estibeiro, P
    Neuritogenic-neurotoxic effects of membrane-associated forms of amyloid precursor protein
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
    
    D. Neill et al., "Neuritogenic-neurotoxic effects of membrane-associated forms of amyloid precursor protein", DEMENT G C, 12(1), 2001, pp. 40-51
50. Broadley, KJ; Kelly, DR
    Muscarinic receptor agonists and antagonists
    MOLECULES
    
    K.J. Broadley e D.R. Kelly, "Muscarinic receptor agonists and antagonists", MOLECULES, 6(3), 2001, pp. 142-193
51. Huse, JT; Doms, RW
    Neurotoxic traffic: Uncovering the mechanics of amyloid production in Alzheimer's disease
    TRAFFIC
    
    J.T. Huse e R.W. Doms, "Neurotoxic traffic: Uncovering the mechanics of amyloid production in Alzheimer's disease", TRAFFIC, 2(2), 2001, pp. 75-81
52. Daugherty, BL; Green, SA
    Endosomal sorting of amyloid precursor protein-P-selectin chimeras influences secretase processing
    TRAFFIC
    
    B.L. Daugherty e S.A. Green, "Endosomal sorting of amyloid precursor protein-P-selectin chimeras influences secretase processing", TRAFFIC, 2(12), 2001, pp. 908-916
53. Watanabe, K; Segawa, T; Nakamura, K; Kodaka, M; Konakahara, T; Okuno, H
    Identification of the molecular interaction site of amyloid beta peptide by using a fluorescence assay
    JOURNAL OF PEPTIDE RESEARCH
    
    K. Watanabe et al., "Identification of the molecular interaction site of amyloid beta peptide by using a fluorescence assay", J PEPT RES, 58(4), 2001, pp. 342-346
54. Linner, E; Popovic, V; Gottfries, CG; Jonsson, M; Sjogren, M; Wallin, A
    The exfoliation syndrome in cognitive impairment of cerebrovascular or Alzheimer's type
    ACTA OPHTHALMOLOGICA SCANDINAVICA
    
    E. Linner et al., "The exfoliation syndrome in cognitive impairment of cerebrovascular or Alzheimer's type", ACT OPHTH S, 79(3), 2001, pp. 283-285
55. Kergoat, H; Kergoat, MJ; Justino, L; Chertkow, H; Robillard, A; Bergman, H
    An evaluation of the retinal nerve fiber layer thickness by scanning laserpolarimetry in individuals with dementia of the Alzheimer type
    ACTA OPHTHALMOLOGICA SCANDINAVICA
    
    H. Kergoat et al., "An evaluation of the retinal nerve fiber layer thickness by scanning laserpolarimetry in individuals with dementia of the Alzheimer type", ACT OPHTH S, 79(2), 2001, pp. 187-191
56. Dukic-Stefanovic, S; Schinzel, R; Riederer, P; Munch, G
    AGES in brain ageing: AGE-inhibitors as neuroprotective and anti-dementia drugs?
    BIOGERONTOLOGY
    
    S. Dukic-Stefanovic et al., "AGES in brain ageing: AGE-inhibitors as neuroprotective and anti-dementia drugs?", BIOGERONTOL, 2(1), 2001, pp. 19-34
57. Studer, R; Baysang, G; Brack, C
    N-acetyl-L-cystein downregulates ss-amyloid precursor protein gene transcription in human neuroblastoma cells
    BIOGERONTOLOGY
    
    R. Studer et al., "N-acetyl-L-cystein downregulates ss-amyloid precursor protein gene transcription in human neuroblastoma cells", BIOGERONTOL, 2(1), 2001, pp. 55-60
58. Petrosian, AA; Prokhorov, DV; Lajara-Nanson, W; Schiffer, RB
    Recurrent neural network-based approach for early recognition of Alzheimer's disease in EEG
    CLINICAL NEUROPHYSIOLOGY
    
    A.A. Petrosian et al., "Recurrent neural network-based approach for early recognition of Alzheimer's disease in EEG", CLIN NEU, 112(8), 2001, pp. 1378-1387
59. Liepert, J; Bar, KJ; Meske, U; Weiller, C
    Motor cortex disinhibition in Alzheimer's disease
    CLINICAL NEUROPHYSIOLOGY
    
    J. Liepert et al., "Motor cortex disinhibition in Alzheimer's disease", CLIN NEU, 112(8), 2001, pp. 1436-1441
60. Matousek, M; Brunovsky, M; Edman, A; Wallin, A
    EEG abnormalities in dementia reflect the parietal lobe syndrome
    CLINICAL NEUROPHYSIOLOGY
    
    M. Matousek et al., "EEG abnormalities in dementia reflect the parietal lobe syndrome", CLIN NEU, 112(6), 2001, pp. 1001-1005
61. Jeong, J; Gore, JC; Peterson, BS
    Mutual information analysis of the EEG in patients with Alzheimer's disease
    CLINICAL NEUROPHYSIOLOGY
    
    J. Jeong et al., "Mutual information analysis of the EEG in patients with Alzheimer's disease", CLIN NEU, 112(5), 2001, pp. 827-835
62. Parisi, V; Restuccia, R; Fattapposta, F; Mina, C; Bucci, MG; Pierelli, F
    Morphological and functional retinal impairment in Alzheimer's disease patients
    CLINICAL NEUROPHYSIOLOGY
    
    V. Parisi et al., "Morphological and functional retinal impairment in Alzheimer's disease patients", CLIN NEU, 112(10), 2001, pp. 1860-1867
63. Santiard-Baron, D; Lacoste, A; Ellouk-Achard, S; Soulie, C; Nicole, A; Sarasin, A; Ceballos-Picot, I
    The amyloid peptide induces early genotoxic damage in human preneuron NT2
    MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
    
    D. Santiard-Baron et al., "The amyloid peptide induces early genotoxic damage in human preneuron NT2", MUT RES-F M, 479(1-2), 2001, pp. 113-120
64. Small, G
    Meeting the challenges of vascular dementia - Introduction
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
    
    G. Small, "Meeting the challenges of vascular dementia - Introduction", INT J CL PR, 2001, pp. 1-4
65. Roman, G
    Diagnosis of vascular dementia and Alzheimer's disease
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
    
    G. Roman, "Diagnosis of vascular dementia and Alzheimer's disease", INT J CL PR, 2001, pp. 9-13
66. Maelicke, A
    The pharmacological rationale for treating vascular dementia with galantamine (Reminyl(Tau Mu))
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
    
    A. Maelicke, "The pharmacological rationale for treating vascular dementia with galantamine (Reminyl(Tau Mu))", INT J CL PR, 2001, pp. 24-28
67. Gauthier, S; Ferris, S
    Outcome measures for probable vascular dementia and Alzheimers disease with cerebrovascular disease
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
    
    S. Gauthier e S. Ferris, "Outcome measures for probable vascular dementia and Alzheimers disease with cerebrovascular disease", INT J CL PR, 2001, pp. 29-39
68. Salib, E; Sheridan, T; Allington, M
    Ventricular measurements in computed tomography of responders and non-responders to donepezil in the treatment of Alzheimer's disease
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
    
    E. Salib et al., "Ventricular measurements in computed tomography of responders and non-responders to donepezil in the treatment of Alzheimer's disease", INT J PSYC, 5(3), 2001, pp. 189-194
69. Fountoulakis, KN; Tsolaki, M; Kazis, A
    Investigation of 'borderline' dementia, particularly of Alzheimer's type, compared with non-demented patients with similar neuropsychological profiles
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
    
    K.N. Fountoulakis et al., "Investigation of 'borderline' dementia, particularly of Alzheimer's type, compared with non-demented patients with similar neuropsychological profiles", INT J PSYC, 5(1), 2001, pp. 55-61
70. Mattson, MP; Duan, W; Pedersen, WA; Culmsee, C
    Neurodegenerative disorders and ischemic brain diseases
    APOPTOSIS
    
    M.P. Mattson et al., "Neurodegenerative disorders and ischemic brain diseases", APOPTOSIS, 6(1-2), 2001, pp. 69-81
71. Zubenko, GS; Hughes, HB; Stiffler, JS
    D10S1423 identifies a susceptibility locus for Alzheimer's disease in a prospective, longitudinal, double-blind study of asymptomatic individuals
    MOLECULAR PSYCHIATRY
    
    G.S. Zubenko et al., "D10S1423 identifies a susceptibility locus for Alzheimer's disease in a prospective, longitudinal, double-blind study of asymptomatic individuals", MOL PSYCHI, 6(4), 2001, pp. 413-419
72. Kunugi, H; Ueki, A; Otsuka, M; Isse, K; Hirasawa, H; Kato, N; Nabika, T; Kobayashi, S; Nanko, S
    A novel polymorphism of the brain-derived neurotrophic factor (BDNF) gene associated with late-onset Alzheimer's disease
    MOLECULAR PSYCHIATRY
    
    H. Kunugi et al., "A novel polymorphism of the brain-derived neurotrophic factor (BDNF) gene associated with late-onset Alzheimer's disease", MOL PSYCHI, 6(1), 2001, pp. 83-86
73. Fleischman, DA; Monti, LA; Dwornik, LM; Moro, TT; Bennett, DA; Gabrieli, JDE
    Impaired production priming and intact identification priming in Alzheimer's disease
    JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY
    
    D.A. Fleischman et al., "Impaired production priming and intact identification priming in Alzheimer's disease", J INT NEURO, 7(7), 2001, pp. 785-794
74. Vanderploeg, RD; Yuspeh, RL; Schinka, JA
    Differential episodic and semantic memory performance in Alzheimer's disease and vascular dementias
    JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY
    
    R.D. Vanderploeg et al., "Differential episodic and semantic memory performance in Alzheimer's disease and vascular dementias", J INT NEURO, 7(5), 2001, pp. 563-573
75. Albert, MS; Moss, MB; Tanzi, R; Jones, K
    Preclinical prediction of AD using neuropsychological tests
    JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY
    
    M.S. Albert et al., "Preclinical prediction of AD using neuropsychological tests", J INT NEURO, 7(5), 2001, pp. 631-639
76. Razani, J; Boone, KB; Miller, BL; Lee, A; Sherman, D
    Neuropsychological performance of right- and left-frontotemporal dementia compared to Alzheimer's disease
    JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY
    
    J. Razani et al., "Neuropsychological performance of right- and left-frontotemporal dementia compared to Alzheimer's disease", J INT NEURO, 7(4), 2001, pp. 468-480
77. Norton, LE; Ostergaard, AL
    Priming performance in Alzheimer's disease: The role of task sensitivity
    JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY
    
    L.E. Norton e A.L. Ostergaard, "Priming performance in Alzheimer's disease: The role of task sensitivity", J INT NEURO, 7(3), 2001, pp. 294-301
78. Fama, R; Shear, PK; Marsh, L; Yesavage, JA; Tinklenberg, JR; Lim, KO; Pfefferbaum, A; Sullivan, EV
    Remote memory for public figures in Alzheimer's disease: Relationships to regional cortical and limbic brain volumes
    JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY
    
    R. Fama et al., "Remote memory for public figures in Alzheimer's disease: Relationships to regional cortical and limbic brain volumes", J INT NEURO, 7(3), 2001, pp. 384-390
79. O'Brien, J; Robinson, L; Fairbairn, A
    Proposed shared care protocol between primary and secondary care for the ongoing management of those on anti-dementia medication
    PRIMARY CARE PSYCHIATRY
    
    J. O'Brien et al., "Proposed shared care protocol between primary and secondary care for the ongoing management of those on anti-dementia medication", PRIM CARE P, 7(3), 2001, pp. 111-113
80. Rausch, DM; Davis, MR
    HIV in the CNS: Pathogenic relationships to systemic HIV disease and otherCNS diseases
    JOURNAL OF NEUROVIROLOGY
    
    D.M. Rausch e M.R. Davis, "HIV in the CNS: Pathogenic relationships to systemic HIV disease and otherCNS diseases", J NEUROVIRO, 7(2), 2001, pp. 85-96
81. Danysz, W
    Neurotoxicity as a mechanism for neurodegenerative disorders: Basic and clinical aspects - March 16-18th 2001, Pucon, Chile
    EXPERT OPINION ON INVESTIGATIONAL DRUGS
    
    W. Danysz, "Neurotoxicity as a mechanism for neurodegenerative disorders: Basic and clinical aspects - March 16-18th 2001, Pucon, Chile", EXPERT OP I, 10(5), 2001, pp. 985-989
82. Emre, M; Qizilbash, N
    Experimental approaches and drugs in development for the treatment of dementia
    EXPERT OPINION ON INVESTIGATIONAL DRUGS
    
    M. Emre e N. Qizilbash, "Experimental approaches and drugs in development for the treatment of dementia", EXPERT OP I, 10(4), 2001, pp. 607-617
83. 
    Peroxynitrile decomposition catalysts and methods of use thereof
    EXPERT OPINION ON THERAPEUTIC PATENTS
    
    EXPERT OP T, 11(7), 2001, pp. 1229-1231
84. Stoessl, AJ
    Antisense strategies for the treatment of neurological disease
    EXPERT OPINION ON THERAPEUTIC PATENTS
    
    A.J. Stoessl, "Antisense strategies for the treatment of neurological disease", EXPERT OP T, 11(4), 2001, pp. 547-562
85. Joyce, JN; Ryoo, H; Gurevich, EV; Adler, C; Beach, T
    Ventral striatal D-3 receptors and Parkinson's disease
    PARKINSONISM & RELATED DISORDERS
    
    J.N. Joyce et al., "Ventral striatal D-3 receptors and Parkinson's disease", PARKINS R D, 7(3), 2001, pp. 225-230
86. Bowirrat, A; Treves, TA; Friedland, RP; Korczyn, AD
    Prevalence of Alzheimer's type dementia in an elderly Arab population
    EUROPEAN JOURNAL OF NEUROLOGY
    
    A. Bowirrat et al., "Prevalence of Alzheimer's type dementia in an elderly Arab population", EUR J NEUR, 8(2), 2001, pp. 119-123
87. Siri, A; Benaglio, I; Frigerio, A; Binetti, G; Cappa, SF
    A brief neuropsychological assessment for the differential diagnosis between frontotemporal dementia and Alzheimer's disease
    EUROPEAN JOURNAL OF NEUROLOGY
    
    A. Siri et al., "A brief neuropsychological assessment for the differential diagnosis between frontotemporal dementia and Alzheimer's disease", EUR J NEUR, 8(2), 2001, pp. 125-132
88. Moretti, R; Torre, P; Antonello, RM; Cazzato, G
    Headache in dementia
    EUROPEAN JOURNAL OF NEUROLOGY
    
    R. Moretti et al., "Headache in dementia", EUR J NEUR, 8(1), 2001, pp. 93-94
89. Heo, HJ; Cho, HY; Hong, BS; Kim, HK; Kim, EK; Kim, BG; Shin, DH
    Protective effect of 4 ',5-dihydroxy-3 ',6,7-trimethoxyflavone from Artemisia asiatica against A beta-indueed oxidative stress in PC12 cells
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
    
    H.J. Heo et al., "Protective effect of 4 ',5-dihydroxy-3 ',6,7-trimethoxyflavone from Artemisia asiatica against A beta-indueed oxidative stress in PC12 cells", AMYLOID, 8(3), 2001, pp. 194-201
90. Dominguez, DI; De Strooper, B; Annaert, W
    Secretases as therapeutic targets for the treatment of Alzheimer's disease
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
    
    D.I. Dominguez et al., "Secretases as therapeutic targets for the treatment of Alzheimer's disease", AMYLOID, 8(2), 2001, pp. 124-142
91. Yang, DS; Serpell, LC; Yip, CM; McLaurin, J; Chrishti, MA; Horne, P; Boudreau, L; Kisilevsky, R; Westaway, D; Fraser, PE
    Assembly of Alzheimer's amyloid-beta fibrils and approaches for therapeutic intervention
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
    
    D.S. Yang et al., "Assembly of Alzheimer's amyloid-beta fibrils and approaches for therapeutic intervention", AMYLOID, 8, 2001, pp. 10-19
92. Gervais, F; Chalifour, R; Garceau, D; Kong, XQ; Laurin, J; McLaughlin, R; Morissette, C; Paquette, J
    Glycosaminoglycan mimetics: a therapeutic approach to cerebral amyloid angiopathy
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
    
    F. Gervais et al., "Glycosaminoglycan mimetics: a therapeutic approach to cerebral amyloid angiopathy", AMYLOID, 8, 2001, pp. 28-35
93. Rebeck, GW; Cho, HS; Grabowski, TJ; Greenberg, SM
    The effects of A beta PP mutations and APOE polymorphisms on cerebral amyloid angiopathy
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
    
    G.W. Rebeck et al., "The effects of A beta PP mutations and APOE polymorphisms on cerebral amyloid angiopathy", AMYLOID, 8, 2001, pp. 43-47
94. Kim, HC; Kim, DK; Choi, IJ; Kang, KH; Yi, SD; Park, J; Park, YN
    Relation of apolipoprotein E polymorphism to clinically diagnosed Alzheimer's disease in the Korean population
    PSYCHIATRY AND CLINICAL NEUROSCIENCES
    
    H.C. Kim et al., "Relation of apolipoprotein E polymorphism to clinically diagnosed Alzheimer's disease in the Korean population", PSY CLIN N, 55(2), 2001, pp. 115-120
95. Yamada, T; Hattori, H; Miura, A; Tanabe, M; Yamori, Y
    Prevalence of Alzheimer's disease, vascular dementia and dementia with Lewy bodies in a Japanese population
    PSYCHIATRY AND CLINICAL NEUROSCIENCES
    
    T. Yamada et al., "Prevalence of Alzheimer's disease, vascular dementia and dementia with Lewy bodies in a Japanese population", PSY CLIN N, 55(1), 2001, pp. 21-25
96. Lamb, HM; Goa, KL
    Rivastigmine - A pharmacoeconomic review of its use in Alzheimer's disease
    PHARMACOECONOMICS
    
    H.M. Lamb e K.L. Goa, "Rivastigmine - A pharmacoeconomic review of its use in Alzheimer's disease", PHARMACOECO, 19(3), 2001, pp. 303-318
97. Martin, LJ
    Neuronal cell death in nervous system development, disease, and injury (Review)
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    
    L.J. Martin, "Neuronal cell death in nervous system development, disease, and injury (Review)", INT J MOL M, 7(5), 2001, pp. 455-478
98. Yang, JD; Feng, GY; Zhang, J; Hui, Z; Breen, G; Clair, DS; He, L
    Is ApoE gene a risk factor for vascular dementia in Han Chinese?
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    
    J.D. Yang et al., "Is ApoE gene a risk factor for vascular dementia in Han Chinese?", INT J MOL M, 7(2), 2001, pp. 217-219
99. Foster, JK
    Selective attention in Alzheimer's disease
    FRONTIERS IN BIOSCIENCE
    
    J.K. Foster, "Selective attention in Alzheimer's disease", FRONT BIOSC, 6, 2001, pp. D135-D153
100. Swertfeger, DK; Hui, DY
     Apolipoprotein E: A cholesterol transport protein with lipid transport-independent cell signaling properties
     FRONTIERS IN BIOSCIENCE
     
     D.K. Swertfeger e D.Y. Hui, "Apolipoprotein E: A cholesterol transport protein with lipid transport-independent cell signaling properties", FRONT BIOSC, 6, 2001, pp. D526-D535